Trajectories of frailty increased more rapidly 4 to 9 years before dementia onset. Even before this acceleration, higher ...

Dementia describes symptoms like memory loss in multiple diseases, and Alzheimer’s is the most common form. Here are the key ...

It is estimated that less than one in ten people with dementia are eligible for treatment with Lecanemab or Leqembi, the ...

We are making progress in the fight against Alzheimer’s disease. The human brain is complex, but prioritizing Alzheimer’s ...

While you can’t count on a spoonful of olive oil to reduce your risk for dementia-related mortality, including it in your ...

Hearing the news that you have a tumour which could shorten your life is something we all dread. But there may be an ...

Dementia strikes all races, but new research suggests thinking declines in poor seniors are often overlooked.Among a ...

Cannabis is emerging as a tool in dementia care, offering relief from anxiety and agitation when traditional medications fall ...

We fully endorse the Editorial1 on the negative opinion of the European Medicines Agency of the use of lecanemab for the treatment of early Alzheimer's disease. Investigators from the European ...

Dementia is a syndrome associated with an ongoing decline of brain function, and although there is currently no cure, it's ...

Europe's medicines watchdog on Thursday partially approved a marketing request for a long-awaited new treatment for Alzheimer's disease, reversing an earlier decision not to give it the green light.

Essence may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.